Literature DB >> 18844846

Vitamin D: criteria for safety and efficacy.

Robert P Heaney1.   

Abstract

The functional status indicator for vitamin D, for both safety and efficacy, is serum 25-hydroxyvitamin D concentration. Efficacy for several health endpoints requires levels of 80 nmol/L or higher. Toxicity occurs at levels of 500 nmol/L or higher. The input needed for efficacy, in addition to typical food and cutaneous inputs, will usually be 1000-2000 IU/day of supplemental cholecalciferol. Toxicity is associated only with excessive supplemental intake (usually well above 20,000 IU/day).

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18844846     DOI: 10.1111/j.1753-4887.2008.00102.x

Source DB:  PubMed          Journal:  Nutr Rev        ISSN: 0029-6643            Impact factor:   7.110


  42 in total

1.  Vitamin D deficiency promotes skeletal muscle hypersensitivity and sensory hyperinnervation.

Authors:  Sarah E Tague; Gwenaëlle L Clarke; Michelle K Winter; Kenneth E McCarson; Douglas E Wright; Peter G Smith
Journal:  J Neurosci       Date:  2011-09-28       Impact factor: 6.167

2.  Ethnic Variations in Serum 25(OH)D Levels and Bone Ultrasound Attenuation Measurements in Blacks and Whites.

Authors:  Rosario Sakamoto; D Thorpe; R Knutsen; L Beeson; S Knutsen
Journal:  J Racial Ethn Health Disparities       Date:  2017-06-21

3.  An infant with hypercalcemia: answers.

Authors:  Stefano Guarino; Pierluigi Marzuillo; Andrea Apicella; Luigi Annicchiarico Petruzzelli; Angela La Manna
Journal:  Pediatr Nephrol       Date:  2013-10-19       Impact factor: 3.714

4.  The JUPITER lipid lowering trial and vitamin D: Is there a connection?

Authors:  William R Ware
Journal:  Dermatoendocrinol       Date:  2010-04

5.  High-dose vitamin D3 supplementation in children and young adults with HIV: a randomized, placebo-controlled trial.

Authors:  Virginia A Stallings; Joan I Schall; Mary L Hediger; Babette S Zemel; Florin Tuluc; Kelly A Dougherty; Julia L Samuel; Richard M Rutstein
Journal:  Pediatr Infect Dis J       Date:  2015-02       Impact factor: 2.129

6.  Vitamin D and Major Chronic Illness.

Authors:  Sadeq A Quraishi; Carlos A Camargo
Journal:  J Restor Med       Date:  2012-09

7.  Blood lead concentration is not altered by high-dose vitamin D supplementation in children and young adults with HIV.

Authors:  Veronique Groleau; Rachel A Herold; Joan I Schall; Julia L Wagner; Kelly A Dougherty; Babette S Zemel; Richard M Rutstein; Virginia A Stallings
Journal:  J Pediatr Gastroenterol Nutr       Date:  2013-03       Impact factor: 2.839

8.  Risk of hypercalcemia in blacks taking hydrochlorothiazide and vitamin D.

Authors:  Paulette D Chandler; Jamil B Scott; Bettina F Drake; Kimmie Ng; John P Forman; Andrew T Chan; Gary G Bennett; Bruce W Hollis; Edward L Giovannucci; Karen M Emmons; Charles S Fuchs
Journal:  Am J Med       Date:  2014-03-20       Impact factor: 4.965

Review 9.  Vitamin D deficiency in early life and the potential programming of cardiovascular disease in adulthood.

Authors:  Oksan Gezmish; Mary Jane Black
Journal:  J Cardiovasc Transl Res       Date:  2013-05-30       Impact factor: 4.132

Review 10.  Progress in osteoporosis and fracture prevention: focus on postmenopausal women.

Authors:  Kenneth G Saag; Piet Geusens
Journal:  Arthritis Res Ther       Date:  2009-10-14       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.